Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/11/2013 | US8461422 DIG-5 insecticidal Cry toxins |
06/11/2013 | US8461421 Toxin genes and methods for their use |
06/11/2013 | US8461420 Alfalfa variety 05N16PY |
06/11/2013 | US8461419 Plant height regulatory gene and uses thereof |
06/11/2013 | US8461418 Enhanced zein reduction in transgenic corn seed |
06/11/2013 | US8461417 Reduction of lyso-phosphatidylcholine acyltransferase activity |
06/11/2013 | US8461416 Methods and materials for conferring resistance to pests and pathogens of plants |
06/11/2013 | US8461415 AXMI-192 family of pesticidal genes and methods for their use |
06/11/2013 | US8461414 Gene having endoreduplication promoting activity |
06/11/2013 | US8461413 Plants having enhanced yield-related traits and a method for making the same |
06/11/2013 | US8461326 SiRNA targeting connective tissue growth factor (CTGF) |
06/11/2013 | US8461323 Characterization of granulocytic ehrlichia and methods of use |
06/11/2013 | US8461322 Plant 1-deoxy-D-xylulose 5-phosphate reductoisomerase |
06/11/2013 | US8461321 Nucleic acids encoding a deletion variant of uPAR |
06/11/2013 | US8461320 Metabolism mutant; nucleic acid cassette |
06/11/2013 | US8461319 Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
06/11/2013 | US8461315 MicroRNAs and uses thereof |
06/11/2013 | US8461309 Inhibitor protein of the wnt signal pathway |
06/11/2013 | US8461301 Synthetic dragline spider silk-like proteins |
06/11/2013 | US8461299 Peptide capable of binding to immunoglobulin |
06/11/2013 | US8461125 Compositions and methods to treat asthma |
06/11/2013 | US8461124 Five- and six-membered conformationally locked 2′,4′-carbocyclic ribo-thymidines for the treatment of infections and cancer |
06/11/2013 | US8461123 Oligonucleotide analogues incorporating 5-aza-cytosine therein |
06/11/2013 | US8461109 Method of enhancing the acceptance and/or healing of a skin graft |
06/11/2013 | US8461101 Targeting PAX2 for the treatment of breast cancer |
06/11/2013 | US8460933 Expression system incorporating a capsid promoter sequence as an enhancer |
06/11/2013 | US8460932 Method of treating a disorder by suicide gene therapy |
06/11/2013 | US8460931 Neural progenitor cells derived from embryonic stem cells |
06/11/2013 | US8460924 Supercoiled minivectors™ for gene therapy applications |
06/11/2013 | US8460920 Method for the purification of adenovirus particles |
06/11/2013 | US8460916 TS-23 alpha-amylase variants with altered properties |
06/11/2013 | US8460915 Escherichia coli expressing the cytochrome P-450 gene and a method for microbial conversion using them |
06/11/2013 | US8460912 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
06/11/2013 | US8460902 DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid |
06/11/2013 | US8460896 Host cells and culture methods |
06/11/2013 | US8460894 Calcium-sensing receptor 2 (CaR2) and methods for using |
06/11/2013 | US8460893 Recombinant microorganism expressing a secY gene and method of use thereof |
06/11/2013 | US8460880 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
06/11/2013 | US8460875 Recombinase polymerase amplification |
06/11/2013 | US8460873 Pancreatic cancer genes |
06/11/2013 | US8460867 Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene |
06/11/2013 | US8460864 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
06/11/2013 | US8460678 Use of triplex structure DNA in transferring nucleotide sequences |
06/11/2013 | CA2694798C Transgenic plants that exhibit enhanced nitrogen assimilation |
06/11/2013 | CA2588243C Corn event das-59122-7 and methods for detection thereof |
06/11/2013 | CA2560581C Pluripotent stem cell growing method |
06/11/2013 | CA2559161C Irna agents targeting vegf |
06/11/2013 | CA2533512C Antagonists and agonists of ldcam and methods of use |
06/11/2013 | CA2520936C An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
06/11/2013 | CA2489196C Method and test kit for quantitative determination of polynucleotides in a mixture |
06/11/2013 | CA2482607C Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
06/11/2013 | CA2481349C Peptides for detection of antibody to a. phagocytophilum |
06/11/2013 | CA2475418C Mutation of dna polymerases from archaeobacteria |
06/11/2013 | CA2468733C Antibodies against monocyte chemotactic proteins |
06/11/2013 | CA2467927C Antimicrobial polypeptides from pseudoplectania nigrella |
06/11/2013 | CA2461123C Bgl3 beta-glucosidase and nucleic acids encoding the same |
06/11/2013 | CA2451002C Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
06/11/2013 | CA2448835C Use of follistatin to increase muscle mass |
06/11/2013 | CA2442839C Production and use of novel peptide-based agents for use with bi-specific antibodies |
06/11/2013 | CA2442022C Method of encoding information in nucleic acids of a genetically engineered organism |
06/11/2013 | CA2437942C Chimeric molecules to modulate gene expression |
06/11/2013 | CA2437453C Conformationally abnormal forms of tau proteins and specific antibodies thereto |
06/11/2013 | CA2407959C Human wingless-like gene |
06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
06/11/2013 | CA2405750C Protein kinase stress-related proteins and methods of use in plants |
06/11/2013 | CA2405473C Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
06/11/2013 | CA2388461C Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
06/11/2013 | CA2377381C Neovascular-targeted immunoconjugates |
06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
06/11/2013 | CA2229307C Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
06/10/2013 | CA2808822A1 High yielding soybean variety xb27p13 |
06/06/2013 | WO2013082591A1 Compositions and methods for modulating myeloid derived suppressor cells |
06/06/2013 | WO2013082551A1 Induced exon inclusion in spinal muscle atrophy |
06/06/2013 | WO2013082529A1 Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery |
06/06/2013 | WO2013082522A1 Expression of g-protein coupled receptors (gpcrs) |
06/06/2013 | WO2013082515A2 Nucleic acid aptamers directed to surface receptors and methods of use |
06/06/2013 | WO2013082366A1 Anti-ceacam1 recombinant antibodies for cancer therapy |
06/06/2013 | WO2013082335A1 COMBINING YELLOW DWARF VIRUS, FUSARIUM HEAD BLIGHT, Ug99 STEM RUST AND LEAF RUST RESISTANCE GENES IN SOFT WINTER WHEAT ADAPTED TO EASTERN USA |
06/06/2013 | WO2013082308A1 Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support |
06/06/2013 | WO2013082304A1 Photonic nanoantenna mediated gene circuit reconfiguration |
06/06/2013 | WO2013082300A1 Methods of evaluating genetic elements |
06/06/2013 | WO2013082288A1 Glucorticoid receptor gene nr3c1 methylation in irritable bowel syndrome and other stress disorders |
06/06/2013 | WO2013082237A1 Compositions and methods for the treatment of viral infections |
06/06/2013 | WO2013082200A1 Novel enhanced selectin antagonists |
06/06/2013 | WO2013081987A1 High throughput single nucleotide polymorphism assay |
06/06/2013 | WO2013081700A1 Overexpression of genes that improve fermentation in yeast using cellulosic substrates |
06/06/2013 | WO2013081612A1 Vectors and host cells comprising a modified sv40 promoter for protein expression |
06/06/2013 | WO2013081571A2 Isolated lyssavirus nucleic acid and protein sequences |
06/06/2013 | WO2013081371A1 Binding molecule generated from human b-cells and capable of neutralizing influenza a viruses |
06/06/2013 | WO2013081296A1 Microorganism for simultaneously producing l-amino acid and riboflavin, and method for producing l-amino acid and riboflavin using same |
06/06/2013 | WO2013081233A1 Cell killing fusion peptide exhibiting tumor cell-specific necrosis induction and tumor regression |
06/06/2013 | WO2013081207A1 Method for simultaneous amplification of target sequences of salmonella species and escherichia coli 0157:h7, and kit for same |
06/06/2013 | WO2013081206A1 Real-time pcr detection using stabilized probe |
06/06/2013 | WO2013081202A1 Oligonucleotide for detecting e. coli o157:h7 and usage of same |
06/06/2013 | WO2013081201A1 Kit for detecting hiv-1 and method for detecting hiv-1 |
06/06/2013 | WO2013081200A1 Kit for detecting hiv-2, and method for detecting hiv-2 using same |
06/06/2013 | WO2013081199A1 Kit for detecting hepatitis b virus and method for detecting hepatitis b virus using same |
06/06/2013 | WO2013081198A1 Kit for detecting hepatitis c virus and method for detecting hepatitis c virus using same |